On 28 May 2026, international experts from academia, industry and healthcare gather for the 16th edition of New Horizons in Biologics & Bioprocessing – a scientifically driven conference highlighting the latest advances in biologics, bioprocessing and advanced therapies. The event focuses on technical and scientific progress rather than commercial perspectives, and brings together key stakeholders from across the life science ecosystem. Organized by Life Science Sweden, in collaboration with Medicon Valley Alliance.
The 2026 programme will present a comprehensive overview of emerging directions and improvements within biologics, bioprocessing and ATMP development. Topics may include analytical techniques, cell culturing and upstream processing, downstream processing, single-use systems, cell and gene therapy, as well as regulatory considerations. Throughout the day, the programme explores how new technologies, processes and methodologies are shaping the future of biologics and bioprocessing.
As one of the leading scientific meetings in the field, the event attracts a broad international audience, including biotech companies of all sizes, researchers from academia and industry, large pharma, contract manufacturing organisations, engineering houses and consultants. In addition to a full seminar agenda, the conference offers extensive networking, a vibrant exhibition with event partners and pre-bookable one-on-one partnering meetings via the Meeting Mojo platform.
Whether attending as a researcher, industry professional or partner, New Horizons in Biologics & Bioprocessing is a key meeting place for knowledge exchange, collaboration and inspiration: a must-attend event for anyone working at the forefront of biologics, bioprocessing and advanced therapies.
Date: Thursday, 28 May 2026
Time: Registration opens at 8:00. Seminars commence approximately 8:45
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 13, 2300 København S, Danmark